A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC

NCT06775275 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Resectable Lung Non-Small Cell Carcinoma

Interventions

DRUG: Adebellizumab
DRUG: Bevacizumab
DRUG: Platinum-based chemotherapy

Sponsor

The First Affiliated Hospital of Guangzhou Medical University